Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study

被引:277
|
作者
Khunti, Kamlesh [1 ,2 ]
Davies, Melanie [1 ,2 ]
Majeed, Azeem [3 ]
Thorsted, Brian Larsen [4 ]
Wolden, Michael Lyng [4 ]
Paul, Sanjoy K. [5 ]
机构
[1] Univ Leicester, Leicester Diabet Ctr, Leicester, Leics, England
[2] Univ Leicester, Leicester Clin Trials Unit, Leicester, Leics, England
[3] Univ London Imperial Coll Sci Technol & Med, Dept Publ Hlth & Primary Care, London, England
[4] Novo Nordisk AS, Bagsvaerd, Denmark
[5] QIMR Berghofer Med Res Inst, Clin Trials & Biostat Unit, Brisbane, Qld, Australia
关键词
GLYCEMIC CONTROL; GLUCOSE CONTROL; COMPLICATIONS; VETERANS; EVENTS;
D O I
10.2337/dc14-0920
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVEHypoglycemia has been associated with an increased risk of cardiovascular (CV) events and all-cause mortality. This study assessed whether, in a nationally representative population, there is an association between hypoglycemia, the risk of CV events, and all-cause mortality among insulin-treated people with type 1 diabetes or type 2 diabetes.RESEARCH DESIGN AND METHODSThis retrospective cohort study used data from the Clinical Practice Research Datalink database and included all insulin-treated patients (30 years of age) with a diagnosis of diabetes.RESULTSIn patients who experienced hypoglycemia, hazard ratios (HRs) for CV events in people with type 1 diabetes were 1.51 (95% CI 0.83, 2.75; P = ns) and 1.61 (1.17, 2.22), respectively, for those with and without a history of CV disease (CVD) before the index date. In people with type 2 diabetes, the HRs for patients with and without a history of CVD were 1.60 (1.21, 2.12) and 1.49 (1.23, 1.82), respectively. For all-cause mortality, HRs in people with type 1 diabetes were 1.98 (1.25, 3.17), and 2.03 (1.66, 2.47), respectively, for those with and without a history of CVD. Among people with type 2 diabetes, HRs were 1.74 (1.39, 2.18) and 2.48 (2.21, 2.79), respectively, for those with and without a history of CVD. The median time (interquartile range) from first hypoglycemia event to first CV event was 1.5 years (0.5, 3.5 years) and 1.5 years (0.5, 3.0 years), respectively, for people with type 1 and type 2 diabetes.CONCLUSIONSHypoglycemia is associated with an increased risk of CV events and all-cause mortality in insulin-treated patients with diabetes. The relationship between hypoglycemia and CV outcomes and mortality exists over a long period.
引用
收藏
页码:316 / 322
页数:7
相关论文
共 50 条
  • [31] Circulating Adiponectin Levels and Risk of Type 2 Diabetes, Cardiovascular Disease, and All-Cause Mortality in US Women
    Hu, Jie
    Li, Jun
    Liang, Liming
    Huang, Tianyi
    Hu, Frank B.
    Manson, Joann E.
    Tworoger, Shelley S.
    Rexrode, Kathryn M.
    CIRCULATION, 2019, 139
  • [32] Television Viewing and Risk of Type 2 Diabetes, Cardiovascular Disease, and All-Cause Mortality A Meta-analysis
    Grontved, Anders
    Hu, Frank B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (23): : 2448 - 2455
  • [33] A Population-Based Study of All-Cause Mortality and Cardiovascular Disease in Association With Prior History of Hypoglycemia Among Patients With Type 1 Diabetes
    Lu, Chin-Li
    Shen, Hsiu-Nien
    Hu, Susan C.
    Wang, Jung-Der
    Li, Chung-Yi
    DIABETES CARE, 2016, 39 (09) : 1571 - 1578
  • [34] High prevalence of impaired awareness of hypoglycemia and severe hypoglycemia among people with insulin-treated type 2 diabetes: The Dutch Diabetes Pearl Cohort
    van Meijel, Lian A.
    de Vegt, Femmie
    Abbink, Evertine J.
    Rutters, Femke
    Schram, Miranda T.
    van der Klauw, Melanie M.
    Wolffenbuttel, Bruce H. R.
    Siegelaar, Sarah
    DeVries, J. Hans
    Sijbrands, Eric J. G.
    Ozcan, Behiye
    de Valk, Harold W.
    Silvius, Bianca
    Schaper, Nicolaas
    Stehouwer, Coen D. A.
    Elders, Petra J. M.
    Tack, Cornelis J.
    de Galan, Bastiaan E.
    BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)
  • [35] Mitral Regurgitation and Increased Risk of All-Cause and Cardiovascular Mortality in Patients with Type 2 Diabetes
    Rossi, Andrea
    Zoppini, Giacomo
    Benfari, Giovanni
    Geremia, Giulia
    Bonapace, Stefano
    Bonora, Enzo
    Vassanelli, Corrado
    Sarano, Maurice Enriquez
    Targher, Giovanni
    CARDIOLOGY, 2016, 134 (02) : 239 - 239
  • [36] Mitral Regurgitation and Increased Risk of All-Cause and Cardiovascular Mortality in Patients with Type 2 Diabetes
    Rossi, Andrea
    Zoppini, Giacomo
    Benfari, Giovanni
    Geremia, Giulia
    Bonapace, Stefano
    Bonora, Enzo
    Vassanelli, Corrado
    Enriquez-Sarano, Maurice
    Targher, Giovanni
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (01): : 70 - +
  • [37] Galectin-3 and risk of cardiovascular events and all-cause mortality in type 2 diabetes
    Tan, Kathryn C. B.
    Cheung, Ching-Lung
    Lee, Alan C. H.
    Lam, Joanne K. Y.
    Wong, Ying
    Shiu, Sammy W. M.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35 (02)
  • [38] Toe-brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuria
    Zobel, Emilie H.
    von Scholten, Bernt Johan
    Reinhard, Henrik
    Persson, Frederik
    Hansen, Tine W.
    Parving, Hans-Henrik
    Jacobsen, Peter K.
    Rossing, Peter
    DIABETOLOGIA, 2017, 60 (10) : 1883 - 1891
  • [39] Association between HbA1c with Cardiovascular (CV) Events and All-Cause Mortality in Elderly Patients with Insulin-treated Type 2 Diabetes (T2D)
    Anyanwagu, Uchenna C.
    Mamza, Jil B.
    Mehta, Rajnikant
    Donnelly, Richard
    Idris, Iskandar
    DIABETES, 2016, 65 : A368 - A368
  • [40] Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus and chronic kidney disease
    Kawada, Tomoyuki
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (03) : 646 - 646